Community-based data show that increasing categories of severity of hypertension according to the 2017 ACC/AHA BP Guidelines are associated with increasing risk of CVD events in middle age.
A small cross-sectional study showed an age-associated rise in BP starting in childhood in a more Westernized community, compared to an isolated, non-acculturated community.
In an observational study, antihypertensive treatment was not associated with reduced mortality or rates of CVD in low-risk patients with mild hypertension.
A retrospective study showed better SBP during antihypertensive therapy and lower risk of antihypertensive treatment failure in hypertensive patients with good oral health, as compared with those with periodontitis.
A community-based lifestyle intervention resulted in greater SBP reduction when compared with health education alone in hypertensive blacks, as observed in the FAITH randomized trial.
BP lowering with amlodipine and lipid lowering with atorvastatin still resulted in lower rates of stroke and CV death in hypertensive patients after more than a decade, as the results of a long-term follow-up of data from the ASCOT trial show.
In patients with a systolic BP between 120 and <140 mmHg, a diastolic BP between 70 and <80 mmHg was associated with a lower risk of adverse outcomes as compared to lower and higher DBP.
One third of patients with newly diagnosed hypertension in this study required more than 125 days for their BP to be controlled. A longer delay in BP control was independently associated with all-cause mortality.
ESC 2018 In this debate, the different viewpoints supporting the European and American Guidelines on Hypertension were fiercely defended, although overlap prevails.
EPCCS 2018 Three professors discuss how best to measure blood pressure, when to call it hypertension, and once hypertension is diagnosed, what BP target to aim for, based on the latest scientific insights.
Black individuals have a significantly higher risk for hypertension compared with whites, from young adulthood through middle age, irrespective of BP before the age of 30 years.
Prof. Hobbs stresses the importance of CVRM in primary care and how to manage this risk beyond glucose control.